The group, which his financed by Blue Shield of California released a position in support of the procedure last year. However, reports of high failure rates from English and Australian databases prompted a reversal of this decision.
Some surgeons performing hip resurfacing argue that studies often overlook the benefits of hip resurfacing that could make it worthwhile for some patient population groups. According to the report, Blue Shield of California will continue covering hip resurfacing for appropriate patients.
Related Articles on Orthopedic Devices:
Zimmer Signs Distribution Agreement for Benvenue Medical’s Vertebral Compression Fracture Treatment System
Stryker’s Net Earnings Decline, Acquisitions Save Sales Growth
K2M Launches Two Lateral Spine Surgery Systems Globally
